Detalhe da pesquisa
1.
Therapeutic Effect of the Mitochondria-Targeted Antioxidant SkQ1 on the Culture Model of Multiple Sclerosis.
Oxid Med Cell Longev
; 2019: 2082561, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31354902
2.
Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis.
Oncogene
; 21(53): 8149-57, 2002 Nov 21.
Artigo
Inglês
| MEDLINE | ID: mdl-12444550
3.
Radioprotective effects of mitochondria-targeted antioxidant SkQR1.
Radiat Res
; 183(1): 64-71, 2015 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-25496313
4.
In search of novel highly active mitochondria-targeted antioxidants: thymoquinone and its cationic derivatives.
FEBS Lett
; 587(13): 2018-24, 2013 Jun 27.
Artigo
Inglês
| MEDLINE | ID: mdl-23665033
5.
Mitochondria-targeted antioxidant SkQR1 selectively protects MDR (Pgp 170)-negative cells against oxidative stress.
FEBS Lett
; 584(3): 562-6, 2010 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-19995561